Intermittent fasting combined with localized Wnt3a treatments has been shown to rejuvenate bone repair in older mice, ...
A breakthrough in life-saving medical technology has arrived. The U.S. Food and Drug Administration (FDA) has officially ...
The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed ...
The U.S. Food and Drug Administration approved Symvess, the first acellular tissue engineered vessel indicated for use in ...